The role of FOXO3a in the development of chemoresistance in breast cancer
Breast cancer is the most common malignancy in women and represents one of the major causes of death worldwide. The PI3K-Akt-FOXO3a signalling pathway has been shown to play a crucial role in tumorigenesis and the development of drug resistance in many cancer types. However, previous studies on FOX...
Main Authors: | Chen, Jie, 陈洁 |
---|---|
Language: | English |
Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10722/180059 |
Similar Items
-
Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance
by: Gorka Ruiz de Garibay, et al.
Published: (2018-05-01) -
Hyperglycemia and Chemoresistance in Breast Cancer: From Cellular Mechanisms to Treatment Response
by: Jie Qiu, et al.
Published: (2021-02-01) -
Epigenetic silencing of microRNA-199b-5p leads to chemoresistance via activation of JAG1 (jagged1) in ovarian cancer
by: Liu, Xin, et al.
Published: (2013) -
New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
by: Junsha An, et al.
Published: (2021-09-01) -
Identification of microRNAs associated with tamoxifen resistance in breast cancer
by: Lau, Lai-yee., et al.
Published: (2013)